Leaflet:information for the patient
BisoprololCombix10 mg film-coated tablets EFG
bisoprolol fumarate
Read the entire leaflet carefullybefore starting to take thismedication,as it contains important informationfor you.
Contents of the leaflet
5 Conservation of Bisoprolol Combix
The active substance of this medication is bisoprolol. Bisoprolol belongs to a group of medications called beta-blockers. These medications work by affecting the body's response to certain nerve impulses, especially in the heart. As a result, bisoprolol slows down the heartbeat and makes the heart more efficient, pumping blood throughout the body. At the same time, bisoprolol reduces the heart's demand for oxygen and blood supply.
Heart failure occurs when the heart muscle is weak and unable to pump enough blood to meet the body's needs.
Bisoprolol is used to:
Do not takeBisoprolol Combix
Do not take bisoprolol if you have any of the following conditions:
Do not take bisoprolol if you have any of the following heart problems:
Warnings and precautions
Consult your doctor or pharmacist before starting to take bisoprolol.
If you have any of the following problems, consult your doctor before starting to take bisoprolol; your doctor may want to take special precautions (such as providing additional treatment or performing more frequent tests):
In addition, inform your doctor if you are going to undergo:
Children and adolescents
The use of bisoprolol is not recommended in this age group.
Other medications and Bisoprolol Combix
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Do not take the following medications with bisoprolol without special advice from your doctor:
Consult your doctor before taking the following medications with bisoprolol; your doctor may need to monitor your condition more frequently:
Pregnancy andbreastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
There is a risk that the use of bisoprolol during pregnancy may harm the baby. If you are pregnant or planning to become pregnant, inform your doctor. Your doctor will decide if you can take this medication during pregnancy.
Breastfeeding
It is not known if bisoprolol passes into human breast milk. Therefore, breastfeeding is not recommended during treatment with bisoprolol.
Driving and using machines
Your ability to drive or use machines may be affected depending on how you tolerate the medication. Be especially careful when starting treatment, when the dose is increased, or the medication is changed, and also in combination with alcohol.
BisoprololCombixcontains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow the administration instructions of this medication exactly as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Treatment with bisoprolol requires regular monitoring by your doctor. This is particularly necessary at the start of treatment, during dose increase, and when stopping treatment.
Take the tablet with a little water in the morning, with or without food. Do not crush or chew the tablet. The tablet can be divided into equal doses.
Treatment with this medication is usually long-term.
Hypertension and angina pectoris
Adults, including elderly patients
The dose should be adjusted individually. The usual daily dose is 10 mg of bisoprolol.
Depending on how well you tolerate the medication, your doctor may decide to reduce the dose to 5 mg or may decide to increase it to 20 mg. The dose should not exceed 20 mg per day.
Chronic stable heart failure
Adults, including elderly patients
Treatment with bisoprolol should be started at a low dose and gradually increased.
Your doctor will decide how to increase the dose, and this will normally be done as follows:
The maximum recommended daily dose is 10 mg of bisoprolol.
Depending on how well you tolerate the medication, your doctor may also decide to prolong the time between dose increases. If your condition worsens or you no longer tolerate the medication, it may be necessary to reduce the dose again or stop treatment. In some patients, a maintenance dose lower than 10 mg of bisoprolol may be sufficient. Your doctor will tell you what to do.
Normally, if you need to stop treatment completely, your doctor will advise you to gradually reduce the dose, as otherwise, your condition may worsen.
Use in patients with renal and/or hepatic impairment
Normally, no dose adjustment is required in patients with mild to moderate renal or hepatic impairment.
In patients with severe renal impairment (creatinine clearance <20 ml min) and in patients with severe hepatic impairment, it is recommended not to exceed 10 mg of bisoprolol once a day.< p>
Use in children and adolescents
The use of bisoprolol is not recommended in this age group.
If you take more Bisoprolol Combix than you should
If you have taken more tablets of bisoprolol than you should, inform your doctor immediately. Your doctor will decide what actions are necessary.
The symptoms of an overdose may include a reduced heart rate, severe difficulty breathing, dizziness, or tremors (due to low blood sugar).
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
If you forget to take Bisoprolol Combix
Do not take a double dose to make up for forgotten doses. Take the usual dose the next morning.
If you stop taking Bisoprolol Combix
Never stop taking bisoprolol unless your doctor tells you to. Otherwise, your condition may worsen significantly. Treatment should not be stopped abruptly, especially in patients with systolic heart failure. If you are considering stopping treatment, your doctor will normally advise you to gradually reduce the dose.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone gets them.
To prevent serious side effects, talk to a doctor immediately if a side effect is severe, occurs suddenly, or worsens rapidly.
The most serious side effects are related to heart function:
If you feel dizzy or weak, or have difficulty breathing, contact your doctor as soon as possible.
Other side effects are mentioned below according to their possible frequency of occurrence:
Frequent(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date stated on the packaging after EXP. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Bisoprolol Combix 10 mg film-coated tablets EFG
Core of the tablet: Silicified microcrystalline cellulose, sodium croscarmellose, type A potato starch carboxymethyl sodium, and magnesium stearate.
Coating of the tablet: coating agent (composed of hypromellose, macrogol, titanium dioxide (E 171), yellow iron oxide (E 172), and red iron oxide (E 172)).
Appearance of the product and contents of the pack
The film-coated tablets are yellow, round, biconvex, with a diameter of approximately 8.50 mm, marked with the inscription "10" on one side and scored on the other.
They are presented in blister packs in containers containing 28, 30, or 60 film-coated tablets.
Marketing authorization holder and manufacturer
Marketing authorization holder
Laboratorios Combix, S.L.U.
C/ Badajoz 2, Edificio 2
28223 Pozuelo de Alarcón (Madrid)
Spain
Manufacturer
Zydus FranceZAC Les Hautes PaturesParc d'activités des Peupliers25 Rue des Peupliers92000 NanterreFrance
or
Centre Specialites Pharmaceutiques
Z.A.C. du Suzot
35 Rue de la Chapelle
63450 Saint Amant Tallende
France
or
Netpharmalab Consulting Services
Carretera de Fuencarral 22,
Alcobendas,
28108 Madrid
Spain
Date of the last revision of this leaflet: April 2025
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)